Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 61.25
(-0.52%)
INR 61.25
(-0.52%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 132.1 Million INR | -58.46% |
| 2022 | 318.01 Million INR | 117.1% |
| 2021 | 146.48 Million INR | 11.0% |
| 2020 | 131.96 Million INR | -26.67% |
| 2019 | 179.97 Million INR | -22.63% |
| 2018 | 232.61 Million INR | -21.71% |
| 2017 | 297.1 Million INR | -18.62% |
| 2016 | 365.07 Million INR | 6.74% |
| 2015 | 342.02 Million INR | 10.97% |
| 2014 | 308.2 Million INR | 11.71% |
| 2013 | 275.9 Million INR | -9.19% |
| 2012 | 303.81 Million INR | 0.0% |
| 2009 | -26.29 Million INR | 66.95% |
| 2008 | -79.56 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q3 | 223.55 Million INR | -43.55% |
| 2023 Q4 | 132.1 Million INR | -40.91% |
| 2023 FY | 132.1 Million INR | -58.46% |
| 2023 Q1 | 280.86 Million INR | -11.68% |
| 2023 Q2 | 396.05 Million INR | 41.01% |
| 2022 Q1 | 282.51 Million INR | 92.87% |
| 2022 Q2 | 246.82 Million INR | -12.63% |
| 2022 Q4 | 318.01 Million INR | 21.42% |
| 2022 Q3 | 261.91 Million INR | 6.11% |
| 2022 FY | 318.01 Million INR | 117.1% |
| 2021 Q2 | 106.57 Million INR | -74.23% |
| 2021 Q4 | 146.48 Million INR | -53.04% |
| 2021 Q3 | 311.94 Million INR | 192.71% |
| 2021 FY | 146.48 Million INR | 11.0% |
| 2021 Q1 | 413.49 Million INR | 213.33% |
| 2020 Q2 | 162.91 Million INR | -49.04% |
| 2020 Q4 | 131.96 Million INR | -42.57% |
| 2020 FY | 131.96 Million INR | -26.67% |
| 2020 Q1 | 319.67 Million INR | 77.63% |
| 2020 Q3 | 229.79 Million INR | 41.05% |
| 2019 Q4 | 179.97 Million INR | -56.25% |
| 2019 FY | 179.97 Million INR | -22.63% |
| 2019 Q3 | 411.35 Million INR | 4.96% |
| 2019 Q2 | 391.93 Million INR | 130.62% |
| 2019 Q1 | 169.95 Million INR | -26.94% |
| 2018 Q4 | 232.61 Million INR | -40.54% |
| 2018 FY | 232.61 Million INR | -21.71% |
| 2018 Q1 | 135.09 Million INR | -54.53% |
| 2018 Q2 | 279.81 Million INR | 107.12% |
| 2018 Q3 | 391.22 Million INR | 39.81% |
| 2017 FY | 297.1 Million INR | -18.62% |
| 2017 Q4 | 297.1 Million INR | 0.0% |
| 2017 Q1 | 54.06 Million INR | 0.0% |
| 2016 FY | 365.07 Million INR | 6.74% |
| 2015 FY | 342.02 Million INR | 10.97% |
| 2014 FY | 308.2 Million INR | 11.71% |
| 2013 FY | 275.9 Million INR | -9.19% |
| 2012 FY | 303.81 Million INR | 0.0% |
| 2009 FY | -26.29 Million INR | 66.95% |
| 2008 FY | -79.56 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.21 Million INR | -423.929% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 69.402% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 396.029% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 273.467% |
| Sunil Healthcare Limited | 625.4 Million INR | 78.878% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 2280.588% |
| MedPlus Health Services Limited | 8.67 Billion INR | 98.478% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 80.838% |
| Patidar Buildcon Limited | 25.12 Million INR | -425.75% |
| Roopa Industries Limited | 216.01 Million INR | 38.847% |
| Smruthi Organics Limited | 111.28 Million INR | -18.7% |
| Trident Lifeline Limited | 117.56 Million INR | -12.368% |
| PANJON LTD. | -12.8 Million INR | 1131.387% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -254.269% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -249.804% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -882.521% |
| Anuh Pharma Limited | -69.8 Million INR | 289.236% |
| Crestchem Limited | -1.45 Million INR | 9210.345% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 317.513% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 1255.731% |
| Tyche Industries Limited | -788.94 Million INR | 116.744% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 87.347% |
| Trimurthi Limited | -1.17 Million INR | 11312.018% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 293.511% |
| Norris Medicines Limited | 214.86 Million INR | 38.519% |
| Zenlabs Ethica Limited | 139.54 Million INR | 5.336% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -242.006% |
| ANG Lifesciences India Limited | 671.01 Million INR | 80.313% |
| Parmax Pharma Limited | 51.8 Million INR | -154.97% |
| Veerhealth Care Limited | -2.38 Million INR | 5638.784% |
| Deccan Health Care Limited | -7.07 Million INR | 1966.874% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 87.382% |
| Makers Laboratories Limited | 172.59 Million INR | 23.461% |
| Lactose (India) Limited | 373.97 Million INR | 64.676% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 76.878% |
| Zenith Healthcare Limited | -25.45 Million INR | 618.914% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 253.694% |
| Bacil Pharma Limited | 569 Thousand INR | -23116.169% |
| PRAVEG LIMITED | -434.98 Million INR | 130.369% |
| Denis Chem Lab Limited | -236.28 Million INR | 155.907% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 85.669% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 116.681% |
| Colinz Laboratories Limited | -64.3 Million INR | 305.434% |
| Godavari Drugs Limited | 530.02 Million INR | 75.076% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 1518.904% |
| Zenotech Laboratories Limited | -196.85 Million INR | 167.105% |
| Panchsheel Organics Limited | -157.82 Million INR | 183.702% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 34.558% |
| Vivanza Biosciences Limited | 50.02 Million INR | -164.063% |
| Phaarmasia Limited | -4.89 Million INR | 2797.57% |
| Sastasundar Ventures Limited | -297.24 Million INR | 144.441% |
| Medi-Caps Limited | -3.21 Million INR | 4210.143% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 241.833% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 345.156% |
| Mercury Laboratories Limited | -26.72 Million INR | 594.22% |
| Gennex Laboratories Limited | -552.54 Million INR | 123.908% |
| BDH Industries Limited | -164.47 Million INR | 180.319% |
| Coral Laboratories Limited | -612.82 Million INR | 121.556% |
| Concord Drugs Limited | 164.48 Million INR | 19.69% |
| Bharat Parenterals Limited | 1.48 Billion INR | 91.127% |
| Beryl Drugs Limited | 48.7 Million INR | -171.208% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -67.844% |
| Evoq Remedies Limited | 41.14 Million INR | -221.036% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -13.636% |
| Transchem Limited | -3.16 Million INR | 4276.415% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 374.648% |
| Parnax Lab Limited | 787.61 Million INR | 83.228% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 325.48% |
| Kerala Ayurveda Limited | 447.82 Million INR | 70.502% |
| Cian Healthcare Limited | 544.97 Million INR | 75.76% |
| Trinity League India Limited | -12 Thousand INR | 1100933.333% |
| Syschem (India) Limited | 3.53 Million INR | -3640.091% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 90.531% |
| Natural Capsules Limited | 956.68 Million INR | 86.192% |
| Auro Laboratories Limited | 252.51 Million INR | 47.686% |